City
Epaper

PM to interact with more teams of Covid-19 vaccine developers

By IANS | Updated: November 29, 2020 20:05 IST

New Delhi, Nov 29 After his visit to three vaccine development centres, Prime Minister Narendra Modi is on ...

Open in App

New Delhi, Nov 29 After his visit to three vaccine development centres, Prime Minister Narendra Modi is on Monday scheduled to speak to three other teams involved in developing a Covid-19 vaccine.

The PMO, in a tweet, said: "Tomorrow, on 30th November 2020, PM Narendra Modi will interact, via video conferencing, with three teams that are involved in developing a COVID-19 vaccine. The teams he will interact with are from Gennova Biopharma, Biological E and Dr Reddy's."

The first two are proceeding with developing their own vaccines, while Dr Reddy's has tied up with Russia to conduct trials of its Sputnik vaccine.

The Prime Minister had visited three cities on Saturday to conduct an extensive review of the vaccine development and manufacturing process, going to the Zydus Biotech Park in Ahmedabad, the Bharat Biotech in Hyderabad and the Serum Institute of India in Pune.

Expressing pride in the fact that India's indigenous vaccine development has progressed at such a rapid pace so far, he had stressed that India considers vaccines as not only vital to good health but also as a global good, and it is India's duty to assist other countries, including the nations in the neighbourhood, in the collective fight against the virus.

Modi asked the scientists to express their free and frank opinion on how the country could further improve its regulatory process. The scientists also presented an overview of how they are also developing various new and repurposed drugs to better fight Covid-19.

After visiting Pune, the Prime Minister had tweeted, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."

The Covidshield vaccine is being developed jointly by the Oxford University, AstraZeneca and the SII, which is the world's largest vaccine manufacturer.

Currently, the SII is producing around 50-60 million doses which would be scaled up to to 100 million by January 2021, SII CEO Adar Poonawalla told the media.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalSouth Korea's senior official reaffirms no unification by absorption or hostile acts toward North Korea

NationalB'luru prison videos: K'taka BJP leaders detained during protest march to CM's residence

NationalISIS suspect’s phone use in jail triggers K'taka crackdown, HM warns of action against officials

NationalMP CM to transfer Rs 300 crore for 1.32 lakh farmers under 'Bhavantar scheme' on Nov 13

BusinessJ&K-base FPO, IREF, & Sarveshwar Foods Sign MoU to Boost Kashmir's Aromatic 'Mushkbudji Rice' Procurement

Health Realted Stories

HealthScreen Addiction May Be Harming Your Fertility; Here’s What You Need to Change Now

HealthStudy finds pregnancy hypertension raises women's cardiovascular risk

HealthStruggling With Belly Fat? Zone Diet May Help Reduce Weight in Just a Week

HealthDengue claims six more lives in Bangladesh, 2025 death toll crosses 310

HealthScientists find brain cells that can stop Alzheimer's: Study